These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 9337537
1. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration. Słodkowska J, Szturmowicz M, Giedronowicz D, Rudzinski P, Sakowicz A, Kupis W. Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537 [Abstract] [Full Text] [Related]
2. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels. Slodkowska J, Szturmowicz M, Rudzinski P, Giedronowicz D, Sakowicz A, Androsiuk W, Zakrzewska-Rowinska E. Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851 [Abstract] [Full Text] [Related]
3. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen. Burg-Kurland CL, Purnell DM, Combs JW, Hillman EA, Harris CC, Trump BF. Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889 [Abstract] [Full Text] [Related]
5. [Tumor markers in the diagnosis of lung cancer]. Marel M, Bíbrová L, Melínová L, Potocková L, Svandová E. Cas Lek Cesk; 1993 Feb 22; 132(4):108-12. PubMed ID: 7682476 [Abstract] [Full Text] [Related]
7. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas? Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni A, Maffini F, Pruneri G, Fraggetta F, Cavallon A, Roz E, Iannucci A, Bresaola E, Viale G. J Pathol; 2002 Sep 22; 198(1):100-9. PubMed ID: 12210069 [Abstract] [Full Text] [Related]
8. [Tumor markers--personal experience. A case report of primary lung cancer with interesting production of tumor markers]. Ariyoshi Y. Gan To Kagaku Ryoho; 1991 Aug 22; 18(10):1721-5. PubMed ID: 1872630 [Abstract] [Full Text] [Related]
9. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K. Anticancer Res; 2000 Aug 22; 20(3B):2177-80. PubMed ID: 10928173 [Abstract] [Full Text] [Related]
16. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer. Załeska J, Pirozynski M, Kwiek S, Sakowicz A, Rowińska-Zakrzewska E. Rocz Akad Med Bialymst; 1997 Sep 22; 42 Suppl 1():179-89. PubMed ID: 9337536 [Abstract] [Full Text] [Related]
17. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. Chen Y, Knösel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I, Petersen I. J Pathol; 2003 Aug 22; 200(5):640-6. PubMed ID: 12898601 [Abstract] [Full Text] [Related]
18. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients]. Higuchi Y. Gan No Rinsho; 1986 Jan 22; 32(1):33-40. PubMed ID: 3005690 [Abstract] [Full Text] [Related]
19. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S. J Pathol; 2004 May 22; 203(1):584-93. PubMed ID: 15095482 [Abstract] [Full Text] [Related]
20. Expression of the laminin gamma2 chain in different histological types of lung carcinoma. A study by immunohistochemistry and in situ hybridization. Määttä M, Soini Y, Pääkkö P, Salo S, Tryggvason K, Autio-Harmainen H. J Pathol; 1999 Aug 22; 188(4):361-8. PubMed ID: 10440745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]